Buffalo, NEW%20YORK2 Active Studies

Spinal Muscular Atrophy Clinical Trials in Buffalo, NEW%20YORK

Find 2 actively recruiting spinal muscular atrophy clinical trials in Buffalo, NEW%20YORK. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
474
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Buffalo

About Spinal Muscular Atrophy Clinical Trials in Buffalo

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 2 spinal muscular atrophy clinical trials recruiting participants in Buffalo, NEW%20YORK. These studies are seeking a combined 474 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA). Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Buffalo — FAQ

Are there spinal muscular atrophy clinical trials in Buffalo?

Yes, there are 2 spinal muscular atrophy clinical trials currently recruiting in Buffalo, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Buffalo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you about next steps.

Are clinical trials in Buffalo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buffalo studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 2 active trials in Buffalo are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov